Previous Article | Next Article 
J Virol, April 1998, p. 2647-2654, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Generation of a Mutant Infectious Bursal Disease
Virus That Does Not Cause Bursal Lesions
Kun
Yao,1,2
Mark A.
Goodwin,3 and
Vikram N.
Vakharia1,2,*
Center for Agricultural Biotechnology,
University of Maryland Biotechnology Institute,1
and
VA-MD Regional College of Veterinary
Medicine,2 University of Maryland, College
Park, Maryland 20742, and
Georgia Poultry
Laboratory, Oakwood, Georgia 305663
Received 29 August 1997/Accepted 16 December 1997
 |
ABSTRACT |
A reverse genetics system for birnavirus, based on synthetic
transcripts of the infectious bursal disease virus (IBDV) genome, was
recently developed (E. Mundt and V. N. Vakharia, Proc. Natl. Acad.
Sci. USA 93:11131-11136, 1996). To study the function of the 17-kDa
nonstructural (NS) protein in viral growth and pathogenesis, we
constructed a cDNA clone of IBDV segment A in which the first and only
initiation codon (ATG) of NS protein was mutated to a stop codon (TAG).
Transfection of Vero cells with combined transcripts of either modified
or unmodified segment A, and with segment B, generated viable IBDV
progeny. When chicken embryo fibroblast cells infected with
transfectant viruses were analyzed by immunofluorescence assays using
NS-specific antiserum, the mutant virus did not yield a fluorescence
signal, indicating a lack of NS protein expression. Furthermore,
replication kinetics and cytotoxic effects of the mutant virus were
compared with those of the parental attenuated vaccine strain of IBDV
(D78) in vitro. The mutant virus grew to slightly lower titers than D78
virus and exhibited decreased cytotoxic and apoptotic effects in cell
culture. To evaluate the characteristics of the recovered viruses in
vivo, we inoculated 3-week-old chickens with D78 or mutant virus and
analyzed their bursa for histopathological lesions. The recovered D78
virus caused microscopic lesions and atrophy of the bursa, while the
mutant virus failed to induce any pathological lesions or clinical
signs of disease. In both instances, the virus was recovered from the
bursa, and the presence or absence of mutation in these viruses was
confirmed by nucleotide sequence analysis of NS gene. Although the
mutant virus exhibited a delay in replication in vivo, it induced
levels of IBDV neutralizing antibodies that were similar to those of
D78 virus. In addition, no reversion of mutation was detected in the
mutant virus recovered from inoculated chickens. These results
demonstrate that NS protein is dispensable for viral replication in
vitro and in vivo and that it plays an important role in viral
pathogenesis. Thus, generation of such NS protein-deficient virus will
facilitate the study of immunosuppression and aid in the development of
live-attenuated vaccines for IBDV.
 |
INTRODUCTION |
Infectious bursal disease virus
(IBDV), a pathogen of economic importance to the poultry industry,
causes severe immunodeficiency in young chickens by destroying the
precursors of antibody-producing B cells in the bursa of Fabricius
(BF). In a fully susceptible flock (between 3 and 6 weeks of age), the
clinical disease causes immunosuppression and is responsible for losses
due to impaired growth and death. Chickens less than 3 weeks of age do
not exhibit outward clinical signs but have a marked infection
characterized by microscopic lesions in the bursa. Damage to the bursa
ultimately causes immunodeficiency, which then leads to an increased
susceptibility to other etiologic agents (9).
IBDV belongs to the genus Avibirnavirus of the
Birnaviridae family, and its genome consists of two segments
of double-stranded RNA (4). The smaller segment B encodes
VP1, a 97-kDa multifunctional protein with polymerase and capping
enzyme activities (21, 22). The larger segment A encodes a
110-kDa precursor protein in a single large open reading frame
(polyprotein ORF) which is processed into mature VP2, VP3, and VP4
proteins (6). VP2 and VP3 are the major structural proteins
of the virion, whereas VP4 is a minor protein involved in the
processing of the precursor protein (8). Segment A also
encodes VP5, a 17-kDa nonstructural (NS) protein, from a small ORF
partly preceding and overlapping the polyprotein ORF. However, this
protein is not present in the virion (2), and it is detected
only in IBDV-infected cells (12). Therefore, VP5 should be
designated an NS protein.
Complete nucleotide sequences of the large segment A of various IBDV
strains have been determined (23). In all cases, the small
ORF, which codes for the 17-kDa NS protein, is invariably present. In
infectious pancreatic necrosis virus (IPNV), a prototype virus of the
Birnaviridae family, segment A also encodes a 17-kDa NS
protein (from a small ORF), which is found in IPNV-infected cells
(10). Although the small ORF coding for NS protein is detected in all birnaviruses studied so far, the function of this protein is still unknown. In IBDV, it was recently shown that NS
protein is not required for viral replication in vitro (13).
The NS protein of IBDV is highly basic, cysteine-rich, and conserved
among all serotype I IBDV strains. In chicken anemia virus, another
virus causing immunosuppression, an analogous basic, cysteine-rich
14-kDa protein was shown to cause apoptosis and was implicated in
pathogenesis (16). Since IBDV is also known to induce
apoptosis in chicken blood lymphocytes (26), we speculated that NS protein of IBDV may play a similar role in pathogenesis.
Therefore, to study the function of NS protein in viral growth and
pathogenesis, we constructed a full-length cDNA clone of segment A of
IBDV vaccine strain D78, in which the initiation codon of the NS gene
was mutated to a stop codon. We also constructed a full-length cDNA
clone of segment B of the homologous IBDV strain. Using the reverse
genetics system, we generated the parent IBDV (D78), as well as a
mutant IBDV that lacked the expression of the NS protein. In this
report, we compare the properties of the recovered D78 IBDV and mutant
IBDV in cell culture and evaluate their pathological functions in the
natural host.
 |
MATERIALS AND METHODS |
Cells and viruses.
Vero cells, used for transfection
experiments, were maintained in medium 199 (M199) supplemented with 5%
fetal bovine serum at 37°C in a humidified 5% CO2
incubator. Primary chicken embryo fibroblast (CEF) cells were prepared
as described previously (14). Secondary CEF cells, used for
virus titration, virus neutralization (VN), immunofluorescence, and
apoptosis assays, were maintained in growth medium consisting of M199
and F10 (50%-50%, vol/vol) and 5% fetal bovine serum. The D78
vaccine strain of IBDV (Intervet Inc., Millsboro, Del.) and its
transcript-derived progeny were plaque purified twice, propagated, and
titrated in secondary CEF cells as described previously
(14). Virus stocks were established by serial passage of the
recovered viruses in CEF cells, at a multiplicity of infection (MOI) of
0.01.
Construction of full-length cDNA clones.
All manipulations
of DNAs were performed according to standard protocols (19).
Construction of a full-length cDNA clone of IBDV genome segment A of
strain D78 has been described previously (14). It encodes
all of the structural proteins (VP2, VP4, and VP3) as well as the NS
protein (Fig. 1). To construct a mutant cDNA clone of segment A lacking the initiation codon of the NS gene,
two primer pairs (see below) were synthesized and used for PCR
amplification of the parent plasmid pUC19FLAD78. These primer pairs,
pUCNde+ (5'-CCATATGCGGTGTGAAATACCG-3', nucleotide positions 482 to 503 in pUC19) plus NS
(5'-CTCTACTAACCTACAATGATAGCG-3', positions 86 to 109 of IBDV segment A) and NS
+ (5'-CGCTATCATTGTAGGTTAGTAGAG-3') plus NdeBV
(5'-CATACCCAAGATCATATGATGTG-3', positions 640 to 662 of segment A), yielded DNA fragments of 342 and 576 bp, respectively. These fragments were combined and subsequently amplified by PCR, using the flanking primers (pUCNde+ and NdeBV) to produce a 918-bp fragment. This fragment was cloned into a pCRII vector (Invitrogen Corp.) to obtain plasmid pCRNS
. This plasmid was digested with NdeI, and the resulting fragment was cloned into
NdeI-cleaved parent plasmid pUC19FLAD78. Finally, a mutant
clone of segment A in which positions 97 and 98 of NS gene initiation
codon (ATG) were substituted to create a stop codon (TAG) was obtained.
A representative mutant clone of segment A was selected and designated pUCD78NS
(Fig. 1).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic presentation of IBDV cDNA constructs for the
generation of plus-sense RNA transcripts with T7 RNA polymerase.
Plasmid pUC19FLAD78 encodes the polyprotein (VP2-VP4-VP3) and the
NS protein (NS) of D78-IBDV. In plasmid pUCD78NS , the initiation
codon of NS gene is mutated to a stop codon. Plasmid pUCD78B encodes
the RNA-dependent RNA polymerase (VP1). All plasmids contain a T7
promoter sequence at their 5'-ends. Plasmids were linearized with the
appropriate restriction enzymes as indicated ( ).
|
|
To construct a cDNA clone of segment B of homologous IBDV strain D78,
two primer pairs (B5'-D78 plus B5-IPD78 and B3'-D78 plus B3-IPD78) were
synthesized and used for reverse transcription (RT)-PCR amplification.
Sequences of the primers were identical to the one used for the
construction of segment B cDNA clone of P2 strain (14). With
genomic double-stranded RNA as a template, cDNA fragments were
synthesized and amplified as specified by the supplier (Perkin-Elmer).
Amplified fragments were cloned between the EcoRI site of a
pCRII vector to obtain plasmids pCRD78A5' and pCRD78A3'. To construct a
full-length clone of segment B, the 5'-end fragment of IBDV (from
plasmid pCRD78B5') was first subcloned between EcoRI and
PstI sites of pUC19 vector to obtain pUCD785'. Then the
3'-end fragment of IBDV (from plasmid pCRD78B3') was inserted between
the unique BglII and PstI sites of plasmid pUCD78B5' to obtain full-length plasmid pUCD78B, which encodes VP1
protein (Fig. 1).
pUCD78NS

and pUCD78B DNA was sequenced by the dideoxy chain
termination method (
20), using an Applied Biosystems
automated
DNA sequencer, and the sequence data were analyzed by using
PC/Gene
(Intelligenetics) software. The integrity of the full-length
constructs
was tested by an in vitro transcription-translation coupled
reticulocyte
lysate system using T7 RNA polymerase (Promega Corp.).
Transcription and transfection of synthetic RNAs.
Transcription and transfection assays were performed as described in
detail previously (14). Briefly, plasmids pUC19FLAD78, pUCD78NS
, and pUCD78B were digested with enzymes BsrGI
and PstI (Fig. 1), respectively, and used as templates for
in vitro transcription with T7 RNA polymerase (Promega). Vero cells
were transfected with combined transcripts of either mutant or
wild-type segment A and of segment B, using Lipofectin reagent
(GIBCO/BRL). The resulting progeny were designated recombinant D78NS
(rD78NS
) and rD78, respectively.
Characterization of transcript-derived IBDV in vitro.
Infection of CEF cells by transcript-derived or transfectant viruses
was analyzed by immunofluorescence assay (IFA) using rabbit anti-IBDV
polyclonal or rabbit anti-NS-specific serum as described before
(14). The anti-NS protein serum was kindly provided by
Egbert Mundt (Federal Research Center for Virus Diseases of Animals,
Insel Riems, Germany). Preparation of this anti-NS protein serum and
its specificity have been described previously (12, 13).
Briefly, CEF cells were infected with rD78 or rD78NS
IBDV at an MOI
of 1 and incubated at 37°C for an appropriate time interval. The
cells were then washed with phosphate-buffered saline, pH 7.4 (PBS),
fixed with ice-cold methanol-acetone (1:1), and treated with either
rabbit anti-NS serum or rabbit anti-IBDV serum. After being washed with
PBS, the cells were treated with fluorescein-labeled goat anti-rabbit
antibody (Kirkegaard & Perry Laboratories) and examined by fluorescence
microscopy.
To examine viral structural proteins expressed by transfectant viruses,
rD78 and rD78NS

IBDV were purified by sucrose and
CsCl gradient
centrifugation as described previously (
15) and
were
adjusted to a protein concentration of 0.1 mg/ml. Equivalent
amounts of
purified viral samples were fractionated on a sodium
dodecyl
sulfate-12.5% polyacrylamide gel, transferred onto a nitrocellulose
membrane, reacted with rabbit anti-IBDV serum, and detected with
streptavidin-alkaline phosphatase and naphthol phosphate fast
red color
development reagents (
24).
Growth curve of IBDV.
To analyze the growth characteristics
of IBDV, confluent secondary CEF cells (in T-25 flasks) were infected
with the parental D78 or with transcript-derived rD78 or rD78NS
virus stock (generated after five passages in CEF cells) at an MOI of
0.1. Infected cell cultures were harvested at different time intervals,
and the titer of infectious virus present in the culture was determined
by plaque assay on CEF cells as described previously (14).
Assays for cell viability and apoptosis.
Cell viability was
measured by the trypan blue exclusion method and by colorimetric MTT
(tetrazolium) (see below) assay (11). For the trypan blue
exclusion method, secondary CEF cells were grown to 80% confluence in
T-25 flask and infected with D78, rD78, or rD78NS
IBDV at an MOI of
1. At daily intervals (up to 7 days), the cells in the cultures were
harvested, trypsinzed, and assayed for viability by using trypan blue
stain (0.4%). For the colorimetric MTT assay, secondary CEF cells were
seeded in 96-well plates at a density of 5 × 104
cells/well and mock infected or infected with either rD78 or rD78NS
IBDV at an MOI of 1. MTT [3-(4,5-dimethythiazol-2-yl)-2,5 diphenyl
tetrazolium bromide; Sigma] was dissolved in serum and phenol-free
medium (5 mg/ml) and filtered just prior to use. At daily intervals (up
to 8 days), 20 µl of MTT solution was added to each well containing
200 µl of phenol-free medium, and the plate was incubated at 37°C
for 2 h in a humidified chamber with 5% CO2. After
the medium was removed, 200 µl of dimethy sulfoxide was added to each
well, and the plates were read at an optical density (OD) of 540 nm in
an enzyme-linked immunosorbent assay (ELISA) reader. The mean of the OD
value
1.0 unit above that of control wells at each day was defined as
100% cell survival. To study apoptosis, secondary CEF cells (grown on
coverslips to 80% confluence) were either mock infected or infected
with transfectant viruses at an MOI of 1 and analyzed by terminal
deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling
(TUNEL) assay. Apoptosis was monitored at 24, 48, and 72 h
postinfection by using the TdT-based In Situ Cell Death
Detection kit (Boehringer Mannheim Corp.), which measures the DNA
strand breakage. Briefly, infected CEF cells (on coverslips) were
washed with PBS, and fixed with freshly made 4% formaldehyde in PBS
for 30 min at room temperature. The fixed cells were rinsed three times
with PBS and then placed (upside down) in a dish containing 50 µl of
TdT labeling mix (1× TdT reaction buffer, 2.5 mM CoCl2,
0.1 mM dithiothreitol, 0.25 U of TdT per ml, 10 mM
fluorescein-16-dUTP). The reaction was carried out at 37°C in a
humidified incubator for 60 min. The cells were then rinsed with PBST
(PBS with 0.1% Triton X-100 and 0.5% Tween 20) and examined by
fluorescence microscopy.
Chicken inoculation and serology.
Three-week-old
specific-pathogen-free (SPF) chickens were obtained (SPAFAS, Inc.,
Storrs, Conn.), and housed in isolators. Prior to inoculation, the
chickens were bled and their sera were tested by ELISA to ensure that
they were negative for IBDV-specific antibodies. Three groups of SPF
chickens (50 in each group) were given one of three treatments
consisting of 2 drops of either culture medium (control), rD78 virus
(5 × 103 PFU/ml), or rD78NS
virus (5 × 103 PFU/ml) into the conjunctival sac. Eight chickens from
each group were removed at 2, 4, 6, 9, and 21 days postinfection and
humanely killed by cerebrocervical separation. The BF was excised from each chicken and bisected. One BF hemisection was stored at
70°C and used for virus isolation and RT-PCR assay. The other BF hemisection was fixed and sectioned for histopathological examination and indirect
IFA as described.
To evaluate the immune response of the mutant virus in vivo, blood
samples were collected from each sampled chicken's ventral
medial wing
vein at 14 and 21 days postinfection. VN antibody
titer was determined
by using parental IBDV strain D78 on CEF
cells as described previously
(
25). The VN titer was reported
as log
2 of the
highest reciprocal dilution that was capable of
neutralizing 500 PFU of
D78 IBDV. In addition, the serum was assayed
for reovirus, Newcastle
disease virus, infectious laryngotracheitis
virus, and infectious
bronchitis virus antibodies by using ELISA
kits (Kirkegaard & Perry
Laboratories).
Characterization of recovered viruses in vivo.
To detect and
isolate the viruses from the chickens inoculated with the transfectant
viruses, the bursa from each sampled chicken was ground in PBS to make
a 10% bursal suspension. One-half milliliter of bursal homogenate was
mixed with 4.5 ml of M199 and passed through 0.45-µm-pore-size
syringe filter. The filtrate was used to infect confluent monolayers of
CEF cells in T-75 flask. The cells were examined daily (up to 5 days)
for the presence or absence of IBDV-specific cytopathic effect. In
addition, the titer of the virus present in these cultures was
determined by plaque assays on CEF cells as described previously
(14).
Identification of recovered viruses by RT-PCR.
Total nucleic
acids of uninfected and IBDV-infected CEF cells or bursal homogenates
were isolated and analyzed by RT-PCR, performed essentially as
described elsewhere (14). Segment A-specific primer
Nhe
(
) (5'-CCCATTGTAGCATGCATCTGTCAG-3', binding to
nucleotide positions 536 to 559) was used for RT of genomic RNA.
Following RT, the reaction products were amplified by PCR using segment A-specific primer A5'-D78 (5'-GGATACGATCGGTCTGACCCCGGGGGAGTCA-3', nucleotide positions 1 to 31). The reaction products were
separated by agarose gel electrophoresis and purified by using a
QIAquick gel extraction kit (Qiagen Inc.). The PCR fragment, comprising the NS gene and the 5' noncoding region of segment A, was cloned into a
pCRII vector and sequenced as described above.
Histopathological studies.
The BF tissues were fixed by
immersion in 10% neutral buffered formalin. The ratio of fixative to
BF exceeded 10:1. Seven days later, a cross-sectional portion of each
BF was processed through paraffin, stained with hematoxylin and eosin,
and examined with a light microscope. The severity of the lesion was
graded on a scale of + to +++ based on the extent of lymphocyte
necrosis, follicular depletion, and atrophy.
 |
RESULTS |
Construction of full-length cDNA clones.
To study the role of
NS protein in IBDV, we constructed a mutant cDNA clone of segment A in
which the first and only initiation codon of the NS gene was mutated to
a stop codon (Fig. 1). Thus, plasmid pUCD78NS
could encode only the
precursor of the structural proteins (VP2, VP4, and VP3). In addition,
we constructed a full-length cDNA clone of segment B of the homologous
IBDV strain D78 which encoded VP1 protein (Fig. 1). Comparison of the
deduced amino acid sequence of D78 segment B with that of the P2 strain
showed 99.97% amino acid identity, indicating that these two European strains are closely related. Coupled transcription and translation of
the above-specified plasmids in a rabbit reticulocyte system yielded
protein products which comigrated with the marker IBDV proteins after
fractionation on a sodium dodecyl sulfate-polyacrylamide gel and
autoradiography (data not shown).
Characterization of generated viruses in vitro.
To study the
function of NS protein in viral replication, Vero cells were
transfected with combined transcripts of segments A and B. As expected,
RNA transcripts of unmodified segments A and B from strain D78
generated rD78. When Vero cells were transfected with combined
transcripts of modified segment A and B, it also generated a viable
mutant virus (rD78NS
). To verify the mutation in rD78NS
, the
genomic RNA was isolated and analyzed by RT-PCR using a primer pair
specific for segment A. Sequence analysis of the cloned PCR product
confirmed the expected nucleotide mutations in the NS gene from the
mutant virus (data not shown). To detect the expression of NS protein,
CEF cells were infected with the recovered viruses and analyzed by IFA
using NS-specific antiserum. Figure 2
shows the results of immunofluorescence staining of IBDV-infected cells. Cells infected with rD78 virus expressed NS protein and gave a
positive immunofluorescence signal (Fig. 2c and f). However, cells
infected with mutant rD78NS
virus failed to give any fluorescence signal, indicating the absence of NS protein expression, even after
passage 10 (Fig. 2b and e). No fluorescence was detected in the
mock-infected cells (Fig. 2a and d).

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 2.
Immunofluorescence staining of IBDV-infected cells used
to detect NS protein expression. CEF cells were infected with passage 1 (b) or passage 10 (e) rD78NS mutant virus stock or with passage 1 (c) or passage 10 (f) rD78 virus stock at an MOI of 1. Uninfected CEF
cells were used as negative controls (a and d). After 24 h
postinfection, the cells were fixed and analyzed by immunofluorescence
staining with rabbit anti-NS protein serum. Magnifications, ×400.
|
|
To determine the replication kinetics of D78, rD78, and rD78NS

, CEF
cells were infected with each virus and the virus titer
was determined
by plaque assay. Figure
3A depicts the
growth curve
of each virus (expressed as log PFU/milliliter) at
different days
postinfection. Our results indicate that the mutant
virus (lacking
the expression of NS protein) replicated somewhat more
slowly
and had a titer that was 1 log lower than that of the parent
vaccine
strain (D78) or recovered (rD78) virus at 6 days
post-infection.
However, the plaques produced by the mutant virus were
similar
in size to those produced by the parental virus. Furthermore,
the transfectant viruses were purified by CsCl gradient, and their
proteins were analyzed by Western blot analysis using IBDV antiserum.
Qualitatively, viral structural proteins (VP2, VP4, and VP3) produced
by the mutant virus were identical to the proteins synthesized
by the
parent D78 or recovered rD78 virus (data not shown). These
results
indicate that NS protein is not required for replication
in cell
culture, in agreement with the recent report by Mundt
et al.
(
13).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Growth curve of IBDV (A) and cytotoxic effect in
IBDV-infected cells (B). (A) Monolayers of CEF cells were infected with
the indicated viruses at an MOI of 0.1 and harvested at the indicated
time points, and infectious titers were determined by plaque assay. (B)
Cell cultures were assayed for viability at the indicated times by the
MTT assay. The mean of the OD value 1.0 unit above that of control
wells at each day was defined as 100% cell survival. Each value is the
average of two independent experiments.
|
|
Cytotoxic and apoptotic effects of recovered viruses.
The
cytopathogenicity of rD78NS
IBDV was compared with that of rD78 or
D78 IBDV in CEF cells by using the MTT assay and trypan blue exclusion
method. Figure 3B shows the cytotoxicity results for these viruses at
different days postinfection with the MTT assay. CEF cells infected
with the parent D78 or rD78 IBDV showed a decrease in cell viability
(40 to 45%) compared to cells infected with rD78NS
IBDV (about
90%). At 3 days postinfection, CEF cells exhibited considerable cell
death due to IBDV replication, which coincided with the virus titer
(Fig. 3A). The viability of CEF cells infected with the mutant virus
(rD78NS
) was almost more than threefold greater than that of cells
infected with the parent (D78) or recovered (rD78) virus at 6 days
postinfection. Similar results were obtained by the trypan blue
exclusion method (data not shown).
IBDV is known to induce apoptosis in chicken blood lymphocytes. To
determine the apoptotic effects of rD78 and rD78NS

IBDV
in CEF
cells, the cells were infected with each virus at an MOI
of 1, harvested at different time points, and analyzed by TUNEL
assay. The
cells infected with rD78 induced apoptosis, as evidenced
by a green
fluorescence signal (Fig.
4c, f, and i).
In contrast,
apoptosis induced by the mutant rD78NS

virus was
significantly
lower than that produced by rD78 (Fig.
4b, e, and h). No
appreciable
level of apoptosis was detected in the mock-infected cells
(Fig.
4a, d, and g). Furthermore, the TUNEL-positive cells were also
quantified in a blinded fashion, as shown in Table
1. The percentage
of apoptotic cells in
the group infected with rD78 virus was significantly
higher (48 to
69%) than that infected with rD78NS

virus (15 to
23%) at 48 h
and 72 h postinfection, respectively. These results
indicate that
IBDV-induced cell death is apparently reduced due
to the absence of NS
protein expression.

View larger version (104K):
[in this window]
[in a new window]
|
FIG. 4.
Analysis of IBDV-induced apoptosis by TUNEL assay. CEF
cells were either mock infected (a, d, and g) or infected with
rD78NS (b, e, and h) or rD78 (c, f, and i) IBDV at an MOI of 1. Cells were fixed at 24 h (a to c), 48 h (d to f), and 72 h (g to i) postinfection and assayed by immunofluorescence for DNA
breakage (TdT assay; green signal). The TUNEL staining of CEF cells,
infected with NS protein-deficient mutant IBDV, show a substantial
reduction in IBDV-induced apoptosis. Magnifications, ×100.
|
|
Histopathological examination of the bursa.
To study the role
of NS protein in viral pathogenesis, groups of 3-week-old SPF chickens
were mock inoculated or inoculated with either rD78 or rD78NS
virus,
and their bursa were analyzed for pathological lesions. Table
2 summarizes the results of
histopathological examination of bursa obtained from different groups
of chickens at selected days postinfection. Chickens inoculated with
rD78 virus showed gross bursal lesions (bursal atrophy) at 6 and 9 days
postinoculation. In addition, this virus produced microscopic lesions
in the bursa at 2, 4, 6, and 9 days postinoculation, as indicated in
Table 2. No gross or microscopic lesions were observed in chickens that
were inoculated with the control medium or rD78NS
virus. Moreover,
histopathologic sections of bursa derived from the control or rD78NS
groups were similar and had normal follicles and follicular connective
tissues (Fig. 5a and b). However, the sections derived from rD78 group showed lymphocytic necrosis and follicular (B-lymphocyte) depletion at 2, 4, 6, and 9 days
postinoculation. Subsequently, extensive accumulation of mononuclear
cells resulted in the loss of distinction between cortex and medulla of
infected bursal section (Fig. 5c). These results clearly indicate that the mutant virus does not cause bursal lesions.

View larger version (108K):
[in this window]
[in a new window]
|
FIG. 5.
Histopathologic appearance of sections (hematoxylin and
eosin) of BF derived from mock-infected and infected chickens at day 6 postinfection. (a) Cortical lymphocytes (dark gray cells adjacent to
connective tissue that separates follicles) and medullary lymphocytes
(light gray cells in follicle centers) in portions of six follicles
from an uninfected chicken are normal. In addition, the interfollicular
connective tissues are normal. (b) Follicles and interfollicular
connective tissues from a chicken infected with the mutant rD78NS
virus are normal and cannot be differentiated from their control
counterparts. (c) There is lymphocytic necrosis and heterophilic
inflammation in six follicles in the BF from a chicken infected with
rD78 virus. Notice the loss of distinction between the cortex and the
medulla and the bands of interfollicular connective tissue that are
infiltrated by myriad heterophils and macrophages. Magnifications,
×100.
|
|
Detection of virus from the bursa.
To detect the presence of
virus in the BF of infected chickens, BF from each group were pooled
and homogenized in M199, and the filtered homogenate was analyzed for
infectivity in CEF cells. After 2 to 3 days postinfection, the virus
was detected (as evidenced by cytopathic effect) in cells infected with
the homogenates of rD78 or rD78NS
groups at 2, 4, 6, and/or 9 days
postinoculation (Table 3). No virus was
detected in 21-day bursal homogenate, indicating that the virus was
cleared from the bursa. As expected, no virus was detected in the
control group. In addition, the presence of viral antigen in the bursal
sections of rD78 and rD78NS
groups was also confirmed by IFA using
IBDV polyclonal antiserum, even on sections that did no show
histopathological lesions at 2, 4, 6, and/or 9 days postinfection (data
not shown). To verify the presence or absence of mutation in the
recovered viruses, whole-cell nucleic acid was isolated from each
bursal homogenate and analyzed by RT-PCR as described above. A 555-bp
fragment was amplified from the homogenates of rD78 and rD78NS
groups at 2, 4, 6, and/or 9 days postinoculation but not from the
control group or from the 21-day bursal homogenates (Table 3).
Genetic stability of recovered viruses.
To determine the
genetic stability of the transfectant viruses in vitro, we propagated
the viruses in CEF cells (up to 10 passages), isolated whole-cell
nucleic acids, and amplified the NS gene by RT-PCR. Sequence analysis
of the cloned PCR product confirmed the expected nucleotide mutations
in the NS gene of the mutant virus, whereas no mutation was detected in
the PCR product of rD78 virus. Similarly, to determine the genetic
stability of these viruses in vivo, chickens were inoculated with
transfectant viruses, and their BF were collected at various days
postinfection. Total nucleic acid was extracted from bursal tissue, and
the NS gene was amplified by RT-PCR using a primer pair specific for segment A. Sequence analysis of the NS gene from the mutant virus revealed the presence of two mutations (97A
T, 98T
A) in bursal samples collected at 2, 4, 6, and 9 days postinfection. As expected, no
nucleotide mutation was detected in the NS gene of the bursal materials
infected with rD78 virus. These results clearly demonstrate that the
mutant virus replicated in the BF of chickens but did not revert to the
parent D78 IBDV.
Replication and immunogenicity of recovered viruses.
To
compare the replication behaviors of recovered viruses in vivo,
chickens were inoculated with equal amounts (5 × 103
PFU) of rD78 and rD78NS
IBDV. Virus titers in the bursa from each
group at different time points were determined by plaque assay on CEF
cells (Table 4). The results indicate
that rD78NS
virus replicated at a lower rate than rD78 virus and its
virus titer reached a peak at day 6 (versus day 2 for rD78 virus),
suggesting a possible role of NS protein during in vivo replication.
Indirect IFA was performed on bursal sections of chickens infected with rD78 and rD78NS
IBDV, using NS-specific antiserum. Bursal sections from chickens infected with rD78 gave a positive immunofluorescence signal at 2 and 4 days postinfection, but the sections from chickens infected with the mutant virus did not give a fluorescence signal, confirming the lack of NS protein expression (data not shown). These
results clearly show that the mutant virus, lacking the expression of
NS protein, efficiently replicated in the BF of chickens.
To compare the immune response induced by rD78 and rD78NS

IBDV,
chickens were inoculated with the recovered viruses and bled
at 14 and
21 days postinoculation, and their sera were analyzed
by the VN test.
VN antibody titers of the sera are shown in Table
4. Although rD78NS

virus replicated at a lower rate than rD78
virus and its titer peaked
at day 6, it induced VN titers that
were comparable to those induced by
the recovered D78 virus at
14 and 21 days postinoculation. These
results indicate that the
mutant virus, which is deficient in producing
NS protein, does
not affect the humoral immune response to IBDV in the
natural
host.
 |
DISCUSSION |
As a first application of IBDV reverse genetics, and to study the
function of NS protein in vivo, we generated an NS protein-deficient virus and demonstrated that the mutant virus can replicate in the bursa
of inoculated chickens but will not induce lesions. This finding
implies that NS protein is directly involved in viral pathogenesis
since the parent IBDV, expressing the NS protein, was able to elicit
pathological response in the natural host. However, the mechanism by
which the NS protein would exert its function remains to be seen.
The NS protein is highly conserved in all serotype I IBDV strains
studied to date (greater than 95% identity). However, the NS protein
of serotype II IBDV strains appears to be different and shows 73%
sequence identity. Since serotype II viruses are naturally avirulent
and do not cause any pathological lesions in chickens (7),
these residues may play a role in the pathogenicity of the virus.
Moreover, in another birnavirus, IPNV, segment A also encodes a 17-kDa
NS protein (from a small ORF), which is found in IPNV-infected cells
(10). Although the reverse genetics system for IPNV is not
available as yet, we would predict a similar function for its NS
protein.
The NS proteins of animal viruses have been shown to play an important
role in viral replication and pathogenesis (1, 3, 16, 17).
For example, the rotavirus NS glycoprotein NSP4 was shown to induce
age-dependent diarrhea in mice (1). In foot-and-mouth disease virus (a picornavirus), the 16-kDa NS protein (leader protease)
was shown to be dispensable for viral replication in vitro and in vivo
(17). Furthermore, this leaderless mutant virus did not
cause lesions in the lung when infected by aerosol and was found to be
nonpathogenic for cattle (3). In chicken anemia virus
(another immunosuppressive virus), a cysteine- and proline-rich, 14-kDa
NS protein (VP3) was shown to cause apoptosis in lymphoblastoid T cells
and was implicated in pathogenesis (16). However, this
protein was found to be essential for viral replication. In our
studies, we showed that NS protein of IBDV is not required for viral
replication in vitro and in vivo, and NS protein-deficient virus does
not cause bursal lesions in vivo. Our results also indicated that
IBDV-induced cell death was significantly reduced due to the absence of
NS protein expression. It would be interesting to know whether the
expression of NS protein alone can induce apoptosis in vitro.
The parental IBDV strain D78 is an attenuated (intermediate) vaccine
strain that is widely used in Europe. This vaccine strain can break
through waning levels of maternal antibodies and elicit a proper immune
response in chickens. However, when chickens are inoculated with an
excessive dose of this virus, it can cause bursal lesions. Our studies
show that the absence of NS protein expression can further attenuate
the virus, and the resultant mutant virus will not induce bursal
lesions, even with a higher inoculation dose (104 PFU/ml).
The NS protein-deficient virus replicated nearly as well as the
parental rD78 virus and was easily recovered from the bursa. Virus
recovered from infected chickens retained the mutation that ablated NS
protein expression, indicating that NS protein is nonessential for
virus replication. It should be noted that NS protein-deficient virus
exhibited a slight delay in replication, whereas the rD78 virus
replicated quickly in chickens and its titer rapidly declined at 6 days
postinfection. In contrast, the mutant virus replicated efficiently in
chickens and its titer reached a peak at 6 days postinfection. It is
evident that infected chickens were able to clear rD78 virus, but not
the mutant virus, at 9 days postinfection. At present, we do not know
why NS protein-deficient virus is able to persist longer than rD78
virus in the natural host. It is known that the major
histocompatibility complex class I-restricted immune response is
important for host against viral infection. It may be possible that the
rD78 complex induces a stronger cytotoxic T-lymphocyte response than
the NS protein-deficient virus. Although the mutant virus replicated at
a slightly lower rate than rD78 virus, it induced VN titers that were
comparable to those induced by D78 virus. This indicates that the
absence of NS protein expression in the mutant virus will not affect
the humoral immune response to IBDV in the natural host. Therefore, it
may be feasible to prepare novel, live-attenuated vaccines for IBDV
that are nonpathogenic to chickens.
Infection of chickens with IBDV results in lymphocyte depletion of the
bursa follicles and bursal necrosis with subsequent immunosuppression.
Since immunoglobulin M-bearing B lymphocytes are the major target cells
for the virus, the proportion of these cells is significantly reduced
after IBDV infection (5, 18). Whether the use of such NS
protein-deficient viruses can cause immunosuppression in chickens
remains to be seen.
 |
ACKNOWLEDGMENTS |
We thank Donald L. Nuss for reviewing the manuscript, and we
thank Gerard H. Edwards, E. Craig Player, and Debrah W. Fuchs for
technical assistance.
This work was supported in part by a grant from the Maryland
Agricultural Experiment Station and U.S. Department of Agriculture (NRICGP grant 97-02492) to V.N.V.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Center for
Agricultural Biotechnology, 6126 Plant Sciences Building, University of Maryland, College Park, MD 20742. Phone: (301) 405-4777. Fax: (301)
314-9075. E-mail: vakharia{at}umbi.umd.edu.
 |
REFERENCES |
| 1.
|
Ball, J. M.,
P. Tian,
C. Q.-Y. Zeng,
A. P. Morris, and M. K. Estes.
1996.
Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein.
Science
272:101-104[Abstract].
|
| 2.
|
Böttcher, B.,
N. A. Kiselev,
V. Y. Stel'Mashchuk,
N. A. Perevozchikova,
A. V. Borisov, and R. A. Crowther.
1997.
Three-dimensional structure of infectious bursal disease virus determined by electron microscopy.
J. Virol.
71:325-330[Abstract].
|
| 3.
|
Brown, C. C.,
M. E. Piccone,
P. W. Mason,
T. S.-C. McKenna, and M. J. Grubman.
1996.
Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle.
J. Virol.
70:5638-5641[Abstract/Free Full Text].
|
| 4.
|
Dobos, P.,
B. J. Hill,
R. Hallet,
D. T. C. Kells,
H. Becht, and D. Teninges.
1979.
Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded genomes.
J. Virol.
32:593-605[Abstract/Free Full Text].
|
| 5.
|
Hirai, K., and B. W. Calnek.
1979.
In vitro replication of infectious bursal disease virus in established cell lines and chicken B lymphocytes.
Infect. Immun.
25:964-970[Abstract/Free Full Text].
|
| 6.
|
Hudson, P. J.,
N. M. McKern,
B. E. Power, and A. A. Azad.
1986.
Genomic structure of the large RNA segment of infectious bursal disease virus.
Nucleic Acids Res.
14:5001-5012[Abstract/Free Full Text].
|
| 7.
|
Ismail, N. M.,
Y. M. Saif, and P. D. Moorhead.
1988.
Lack of pathogenicity of five serotype 2 infectious bursal disease viruses.
Avian Dis.
32:757-759[Medline].
|
| 8.
|
Jagadish, M. N.,
V. J. Staton,
P. L. Hudson, and A. A. Azad.
1988.
Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide.
J. Virol.
62:1084-1087[Abstract/Free Full Text].
|
| 9.
|
Kibenge, F. S. B.,
A. S. Dhillon, and R. G. Russell.
1988.
Biochemistry and immunology of infectious bursal disease virus.
J. Gen. Virol.
69:1757-1775[Abstract/Free Full Text].
|
| 10.
|
Magyar, G., and P. Dobos.
1994.
Evidence for the detection of the infectious pancreatic necrosis virus polyprotein and the 17-kDa polypeptide in infected cells and of the NS protease in purified virus.
Virology
204:580-589[Medline].
|
| 11.
|
Mosmann, T.
1983.
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay.
J. Immunol. Methods
65:1170-1174.
|
| 12.
|
Mundt, E.,
J. Beyer, and H. Müller.
1995.
Identification of a novel viral protein in infectious bursal disease virus-infected cells.
J. Gen. Virol.
76:437-443[Abstract/Free Full Text].
|
| 13.
|
Mundt, E.,
B. Köllner, and D. Kretzschmar.
1997.
VP5 of infectious bursal disease virus is not essential for viral replication in cell culture.
J. Virol.
71:5647-5651[Abstract].
|
| 14.
|
Mundt, E., and V. N. Vakharia.
1996.
Synthetic transcripts of double-stranded birnavirus genome are infectious.
Proc. Natl. Acad. Sci. USA
93:11131-11136[Abstract/Free Full Text].
|
| 15.
|
Nick, H.,
H. Müller, and H. Becht.
1976.
Structural and growth characteristic of infectious bursal disease virus.
J. Virol.
18:227-234[Abstract/Free Full Text].
|
| 16.
|
Noteborn, M. H. M.,
D. Todd,
C. A. J. Verschueren,
H. W. F. M. De Gauw,
W. L. Curran,
S. Veldkamp,
A. J. Douglas,
M. S. McNulty,
A. J. van der Eb, and G. Koch.
1994.
A single chicken anemia virus protein induces apoptosis.
J. Virol.
68:346-351[Abstract/Free Full Text].
|
| 17.
|
Piccone, M. E.,
E. Rieder,
P. W. Mason, and M. J. Grubman.
1995.
The foot-and-mouth disease virus leader proteinase gene is not required for viral replication.
J. Virol.
69:5376-5382[Abstract].
|
| 18.
|
Rodenberg, J.,
J. M. Sharma,
S. W. Belzer,
R. M. Nordgren, and S. Naqi.
1994.
Flow cytometric analysis of B cell and T cell subpopulations in specific-pathogen-free chicken infected with bursal disease virus.
Avian Dis.
38:16-21[Medline].
|
| 19.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 20.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 21.
|
Spies, U., and H. Müller.
1990.
Demonstration of enzyme activities required for the cap structure formation in infectious bursal disease virus, a member of the birnavirus group.
J. Gen. Virol.
17:977-981.
|
| 22.
|
Spies, U.,
H. Müller, and H. Becht.
1987.
Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products.
Virus Res.
8:127-140[Medline].
|
| 23.
|
Vakharia, V. N.,
J. He,
B. Ahamed, and D. B. Snyder.
1994.
Molecular basis of antigenic variation in infectious bursal disease virus.
Virus Res.
31:265-273[Medline].
|
| 24.
|
Vakharia, V. N.,
D. B. Snyder,
J. He,
G. H. Edwards,
P. K. Savage, and S. A. Mengel-Whereat.
1993.
Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens.
J. Gen. Virol.
74:1201-1206[Abstract/Free Full Text].
|
| 25.
|
Vakharia, V. N.,
D. B. Snyder,
D. Lütticken,
S. A. Mengel-Whereat,
P. K. Savage,
G. H. Edwards, and M. A. Goodwin.
1994.
Active and passive protection against variant and classic infectious bursal disease virus induced by baculovirus expressed structural proteins.
Vaccine
12:452-456[Medline].
|
| 26.
|
Vasconcelos, A. C., and K. M. Lam.
1994.
Apoptosis induced by infectious bursal disease virus.
J. Gen. Virol.
75:1803-1806[Abstract/Free Full Text].
|
J Virol, April 1998, p. 2647-2654, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Delgui, L., Gonzalez, D., Rodriguez, J. F.
(2009). Infectious bursal disease virus persistently infects bursal B-lymphoid DT40 cells. J. Gen. Virol.
90: 1148-1152
[Abstract]
[Full Text]
-
Wong, R. T.-Y., Hon, C.-C., Zeng, F., Leung, F. C.-C.
(2007). Screening of differentially expressed transcripts in infectious bursal disease virus-induced apoptotic chicken embryonic fibroblasts by using cDNA microarrays. J. Gen. Virol.
88: 1785-1796
[Abstract]
[Full Text]
-
Liu, M., Vakharia, V. N.
(2006). Nonstructural protein of infectious bursal disease virus inhibits apoptosis at the early stage of virus infection.. J. Virol.
80: 3369-3377
[Abstract]
[Full Text]
-
Nouen, C. L., Rivallan, G., Toquin, D., Darlu, P., Morin, Y., Beven, V., de Boisseson, C., Cazaban, C., Comte, S., Gardin, Y., Eterradossi, N.
(2006). Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate. J. Gen. Virol.
87: 209-216
[Abstract]
[Full Text]
-
Villanueva, R. A., Galaz, J. L., Valdes, J. A., Jashes, M. M., Sandino, A. M.
(2004). Genome Assembly and Particle Maturation of the Birnavirus Infectious Pancreatic Necrosis Virus. J. Virol.
78: 13829-13838
[Abstract]
[Full Text]
-
Galloux, M., Chevalier, C., Henry, C., Huet, J.-C., Costa, B. D., Delmas, B.
(2004). Peptides resulting from the pVP2 C-terminal processing are present in infectious pancreatic necrosis virus particles. J. Gen. Virol.
85: 2231-2236
[Abstract]
[Full Text]
-
Maraver, A., Clemente, R., Rodriguez, J. F., Lombardo, E.
(2003). Identification and Molecular Characterization of the RNA Polymerase-Binding Motif of Infectious Bursal Disease Virus Inner Capsid Protein VP3. J. Virol.
77: 2459-2468
[Abstract]
[Full Text]
-
Brandt, M., Yao, K., Liu, M., Heckert, R. A., Vakharia, V. N.
(2001). Molecular Determinants of Virulence, Cell Tropism, and Pathogenic Phenotype of Infectious Bursal Disease Virus. J. Virol.
75: 11974-11982
[Abstract]
[Full Text]
-
Jungmann, A., Nieper, H., Müller, H.
(2001). Apoptosis is induced by infectious bursal disease virus replication in productively infected cells as well as in antigen-negative cells in their vicinity. J. Gen. Virol.
82: 1107-1115
[Abstract]
[Full Text]
-
Weber, S., Fichtner, D., Mettenleiter, T. C., Mundt, E.
(2001). Expression of VP5 of infectious pancreatic necrosis virus strain VR299 is initiated at the second in-frame start codon. J. Gen. Virol.
82: 805-812
[Abstract]
[Full Text]
-
Schröder, A., van Loon, A. A. W. M., Goovaerts, D., Teifke, J. P., Mundt, E.
(2001). VP5 and the N terminus of VP2 are not responsible for the different pathotype of serotype I and II infectious bursal disease virus. J. Gen. Virol.
82: 159-169
[Abstract]
[Full Text]
-
Schröder, A., van Loon, A. A. W. M., Goovaerts, D., Mundt, E.
(2000). Chimeras in noncoding regions between serotypes I and II of segment A of infectious bursal disease virus are viable and show pathogenic phenotype in chickens. J. Gen. Virol.
81: 533-540
[Abstract]
[Full Text]
-
Tacken, M. G. J., Rottier, P. J. M., Gielkens, A. L. J., Peeters, B. P. H.
(2000). Interactions in vivo between the proteins of infectious bursal disease virus: capsid protein VP3 interacts with the RNA-dependent RNA polymerase, VP1. J. Gen. Virol.
81: 209-218
[Abstract]
[Full Text]
-
Lombardo, E., Maraver, A., Castón, J. R., Rivera, J., Fernández-Arias, A., Serrano, A., Carrascosa, J. L., Rodriguez, J. F.
(1999). VP1, the Putative RNA-Dependent RNA Polymerase of Infectious Bursal Disease Virus, Forms Complexes with the Capsid Protein VP3, Leading to Efficient Encapsidation into Virus-Like Particles. J. Virol.
73: 6973-6983
[Abstract]
[Full Text]
-
Lim, B.-L., Cao, Y., Yu, T., Mo, C.-W.
(1999). Adaptation of Very Virulent Infectious Bursal Disease Virus to Chicken Embryonic Fibroblasts by Site-Directed Mutagenesis of Residues 279 and 284 of Viral Coat Protein VP2. J. Virol.
73: 2854-2862
[Abstract]
[Full Text]
-
Yao, K., Vakharia, V. N.
(1998). Generation of Infectious Pancreatic Necrosis Virus from Cloned cDNA. J. Virol.
72: 8913-8920
[Abstract]
[Full Text]